FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308396321> ?p ?o ?g. }

• W4308396321 abstract "<h3>Background</h3> Interleukin (IL)-27 is a heterodimeric cytokine expressed by myeloid cells that is known to reduce the intensity and duration of immune responses. IL-27 signaling via IL-27RA receptor augments the expression of co-inhibitory molecules (PD-L1, LAG-3, TIM-3, and TIGIT) on immune cells and reduces proinflammatory cytokines in the tumor microenvironment. Blocking IL-27 activity by SRF388, a first-in-class monoclonal antibody, enhances immune function and demonstrates monotherapy activity in patients with cancer (NCT04374877). This study further characterizes the expression of IL-27 in primary solid tumors. <h3>Methods</h3> Gene expression profiles from published datasets were analyzed to identify <i>IL27</i> and <i>IL27RA</i> transcripts. Immunohistochemistry (IHC) and flow cytometry were used to quantify IL-27, PD-L1, and IL-27RA expression in primary tumors. IL-27 levels were measured in cell culture media of primary tumor cells and activated peripheral blood mononuclear cells (PBMCs) by ELISA. <h3>Results</h3> Primary tumor samples showed IL-27 expression by IHC within morphologically defined tumor-associated macrophages (TAMs) in several cancers, including lung, liver, renal, gastric, and head and neck. This is consistent with single-cell RNA-seq transcriptional data showing predominant expression in macrophages from several tumor types. Interestingly, IL-27⁺ TAMs are localized in the vicinity of PD-L1–expressing cells in gastric, lung, and liver tumors, where the highest IL-27⁺ TAM density is associated with the highest expression of PD-L1. Expression of IL-27RA in tumor tissues was also explored by IHC. IL-27RA expression was identified on tumor cells in several cancers and included examples where tumor cell expression of the receptor was maintained at sites of lymph node metastasis. In vitro cultures of activated PBMCs showed that IL-27 increased PD-L1 expression on immune cells, an effect that was further amplified in the presence of dissociated primary tumors co-cultured with activated PBMCs. IL-27 levels were higher in co-cultures of activated PBMCs and dissociated primary tumors than in cultures of PBMCs alone. Finally, IL-27 was shown to upregulate PD-L1 expression on tumor cell lines that express IL-27RA. <h3>Conclusions</h3> IL-27 is expressed by TAMs and plays a role in immune suppression. IL-27⁺ cells are found in close proximity to PD-L1⁺ cells in patient tumors, and IL-27 can regulate levels of PD-L1 expression in immune cells and tumor cell lines, suggesting cross-talk between these molecules to diminish immune activation within the tumor microenvironment. Combined blockade of IL-27 and PD-(L)1 to enhance antitumor immune responses is currently being evaluated in clinical trials." @default.
• W4308396321 created "2022-11-11" @default.
• W4308396321 creator A5007690810 @default.
• W4308396321 creator A5012423011 @default.
• W4308396321 creator A5024081264 @default.
• W4308396321 creator A5026760473 @default.
• W4308396321 creator A5034493173 @default.
• W4308396321 creator A5079332376 @default.
• W4308396321 creator A5080304698 @default.
• W4308396321 creator A5088385429 @default.
• W4308396321 date "2022-11-01" @default.
• W4308396321 modified "2023-09-25" @default.
• W4308396321 title "1082 IL-27 expressed in the tumor microenvironment is correlated with PD-L1 levels and can induce PD-L1 expression on immune and tumor cells" @default.
• W4308396321 doi "https://doi.org/10.1136/jitc-2022-sitc2022.1082" @default.
• W4308396321 hasPublicationYear "2022" @default.
• W4308396321 type Work @default.
• W4308396321 citedByCount "0" @default.
• W4308396321 crossrefType "proceedings-article" @default.
• W4308396321 hasAuthorship W4308396321A5007690810 @default.
• W4308396321 hasAuthorship W4308396321A5012423011 @default.
• W4308396321 hasAuthorship W4308396321A5024081264 @default.
• W4308396321 hasAuthorship W4308396321A5026760473 @default.
• W4308396321 hasAuthorship W4308396321A5034493173 @default.
• W4308396321 hasAuthorship W4308396321A5079332376 @default.
• W4308396321 hasAuthorship W4308396321A5080304698 @default.
• W4308396321 hasAuthorship W4308396321A5088385429 @default.
• W4308396321 hasBestOaLocation W43083963211 @default.
• W4308396321 hasConcept C121608353 @default.
• W4308396321 hasConcept C159654299 @default.
• W4308396321 hasConcept C167672396 @default.
• W4308396321 hasConcept C203014093 @default.
• W4308396321 hasConcept C204232928 @default.
• W4308396321 hasConcept C2776090121 @default.
• W4308396321 hasConcept C2776107976 @default.
• W4308396321 hasConcept C2777701055 @default.
• W4308396321 hasConcept C2778326572 @default.
• W4308396321 hasConcept C2778690821 @default.
• W4308396321 hasConcept C2779118045 @default.
• W4308396321 hasConcept C2779256057 @default.
• W4308396321 hasConcept C2781053074 @default.
• W4308396321 hasConcept C502942594 @default.
• W4308396321 hasConcept C54355233 @default.
• W4308396321 hasConcept C86803240 @default.
• W4308396321 hasConcept C8891405 @default.
• W4308396321 hasConceptScore W4308396321C121608353 @default.
• W4308396321 hasConceptScore W4308396321C159654299 @default.
• W4308396321 hasConceptScore W4308396321C167672396 @default.
• W4308396321 hasConceptScore W4308396321C203014093 @default.
• W4308396321 hasConceptScore W4308396321C204232928 @default.
• W4308396321 hasConceptScore W4308396321C2776090121 @default.
• W4308396321 hasConceptScore W4308396321C2776107976 @default.
• W4308396321 hasConceptScore W4308396321C2777701055 @default.
• W4308396321 hasConceptScore W4308396321C2778326572 @default.
• W4308396321 hasConceptScore W4308396321C2778690821 @default.
• W4308396321 hasConceptScore W4308396321C2779118045 @default.
• W4308396321 hasConceptScore W4308396321C2779256057 @default.
• W4308396321 hasConceptScore W4308396321C2781053074 @default.
• W4308396321 hasConceptScore W4308396321C502942594 @default.
• W4308396321 hasConceptScore W4308396321C54355233 @default.
• W4308396321 hasConceptScore W4308396321C86803240 @default.
• W4308396321 hasConceptScore W4308396321C8891405 @default.
• W4308396321 hasLocation W43083963211 @default.
• W4308396321 hasOpenAccess W4308396321 @default.
• W4308396321 hasPrimaryLocation W43083963211 @default.
• W4308396321 hasRelatedWork W2322919275 @default.
• W4308396321 hasRelatedWork W2485024460 @default.
• W4308396321 hasRelatedWork W2739981013 @default.
• W4308396321 hasRelatedWork W3136393438 @default.
• W4308396321 hasRelatedWork W3163236182 @default.
• W4308396321 hasRelatedWork W4223616468 @default.
• W4308396321 hasRelatedWork W4294343969 @default.
• W4308396321 hasRelatedWork W4308396321 @default.
• W4308396321 hasRelatedWork W4318755152 @default.
• W4308396321 hasRelatedWork W66831786 @default.
• W4308396321 isParatext "false" @default.
• W4308396321 isRetracted "false" @default.
• W4308396321 workType "article" @default.